Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labour.
This report contains market size and forecasts of Atosiban in global, including the following market information:
Global Atosiban Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Atosiban Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Atosiban companies in 2021 (%)
The global Atosiban market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atosiban include Ferring Pharmaceuticals, Sun Pharma, Shanghai Soho-Yiming Pharmaceuticals, EVER Pharma, Hangzhou Longshine Bio-Tech, Cayman Chemical and Neore Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atosiban manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atosiban Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Atosiban Market Segment Percentages, by Type, 2021 (%)
Injection
Concentrate
Global Atosiban Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Atosiban Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Online Pharmacies
Global Atosiban Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Atosiban Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atosiban revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Atosiban revenues share in global market, 2021 (%)
Key companies Atosiban sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Atosiban sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ferring Pharmaceuticals
Sun Pharma
Shanghai Soho-Yiming Pharmaceuticals
EVER Pharma
Hangzhou Longshine Bio-Tech
Cayman Chemical
Neore Pharmaceutical